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Introduction / objectives
Multipatient use of a single-patient CBSD occurred in
an outpatient clinic during 4 to 16 months before its
notification. We looked for transmission of blood-borne
pathogens among exposed patients.
Methods
Exposed patients underwent serology testing for HBV,
HCV and HIV. Patients with isolated anti-HBc received
one dose of hepatitis B vaccine to look for a memory
immune response. Possible transmissions were investi-
gated by mapping visits and sequencing of the viral gen-
ome if needed.
Results
Of 280 exposed patients, 9 had died without suspicion
of blood-borne infection, 3 could not be tested, and 5
declined investigations. Among the 263 (93%) tested
patients, 218 (83%) had negative results. We confirmed
a known history of HCV infection in 6 patients (1 co-
infected by HIV), and also identified resolved HBV
infection in 37 patients, of whom 18 were already
known. 2 patients were found to have a previously
unknown HCV infection. According to the time elapsed
from the closest previous visit of a HCV-infected poten-
tial source patient, we could rule out nosocomial trans-
mission in one case (14 weeks) but not in the other (1
day). In the latter, however, transmission was deemed
very unlikely by 2 reference centers based on the
sequences of the E1 and HVR1 regions of the virus.
Conclusion
We did not identify any transmission of blood-borne
pathogens in 263 patients exposed to a single-patient
CBSD, despite the presence of potential source cases.
Change of needle and disinfection of the device between
patients may have contributed to this outcome.
Although we cannot exclude transmission of HBV, pre-
vious acquisition in endemic countries is a more likely
explanation in this multi-national population.
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